| Basics |
iCAD, Inc. Common Stock
icad Inc is a provider of image analysis, work flow solutions and radiation therapy for early identification and treatment of cancer. The company has cancer detection and cancer therapy segments.
|
| IPO Date: |
December 1, 1984 |
| Sector: |
Healthcare |
| Industry: |
Health Care Technology |
| Market Cap: |
$103.32M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.14 | 3.29%
|
| Avg Daily Range (30 D): |
$0.07 | 1.97%
|
| Avg Daily Range (90 D): |
$0.10 | 3.62%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.14M |
| Avg Daily Volume (30 D): |
1.26M |
| Avg Daily Volume (90 D): |
.73M |
| Trade Size |
| Avg Trade Size (Sh.): |
226 |
| Avg Trade Size (Sh.) (30 D): |
232 |
| Avg Trade Size (Sh.) (90 D): |
213 |
| Institutional Trades |
| Total Inst.Trades: |
53 |
| Avg Inst. Trade: |
$1.64M |
| Avg Inst. Trade (30 D): |
$1.04M |
| Avg Inst. Trade (90 D): |
$1.04M |
| Avg Inst. Trade Volume: |
.18M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.73M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
463.07K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.2
|
$-.03
|
$-.03
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ 19.53M
|
$ 4.87M
|
$ 5.41M
|
|
Gross Profit
|
$ 16.71M
|
$ 4.19M
|
$ 4.67M
|
|
Net Income / Loss
|
$ -5.23M
|
$ -.83M
|
$ -.85M
|
|
Operating Income / Loss
|
$ -5.96M
|
$ -1.13M
|
$ -.87M
|
|
Cost of Revenue
|
$ 2.82M
|
$ .69M
|
$ .74M
|
|
Net Cash Flow
|
$ 2.83M
|
$ 2.83M
|
$ M
|
|
PE Ratio
|
|
|
|
|
